Company Quick10K Filing
Cooper Companies
10-Q 2020-04-30 Filed 2020-06-05
10-Q 2020-01-31 Filed 2020-03-06
10-K 2019-10-31 Filed 2019-12-20
10-Q 2019-07-31 Filed 2019-08-30
10-Q 2019-04-30 Filed 2019-05-31
10-Q 2019-01-31 Filed 2019-03-06
10-K 2018-10-31 Filed 2018-12-21
10-Q 2018-07-31 Filed 2018-08-31
10-Q 2018-04-30 Filed 2018-06-08
10-Q 2018-01-31 Filed 2018-03-09
10-K 2017-10-31 Filed 2017-12-22
10-Q 2017-07-31 Filed 2017-09-01
10-Q 2017-04-30 Filed 2017-06-02
10-Q 2017-01-31 Filed 2017-03-03
10-K 2016-10-31 Filed 2016-12-22
10-Q 2016-07-31 Filed 2016-09-02
10-Q 2016-04-30 Filed 2016-06-03
10-Q 2016-01-31 Filed 2016-03-04
10-K 2015-10-31 Filed 2015-12-18
10-Q 2015-07-31 Filed 2015-09-04
10-Q 2015-04-30 Filed 2015-06-05
10-Q 2015-01-31 Filed 2015-03-06
10-K 2014-10-31 Filed 2014-12-19
10-Q 2014-07-31 Filed 2014-09-05
10-Q 2014-04-30 Filed 2014-06-06
10-Q 2014-01-31 Filed 2014-03-07
10-K 2013-10-31 Filed 2013-12-20
10-Q 2013-07-31 Filed 2013-09-06
10-Q 2013-04-30 Filed 2013-06-07
10-Q 2013-01-31 Filed 2013-03-08
10-K 2012-10-31 Filed 2012-12-20
10-Q 2012-07-31 Filed 2012-09-07
10-Q 2012-04-30 Filed 2012-06-08
10-Q 2012-01-31 Filed 2012-03-09
10-K 2011-10-31 Filed 2011-12-16
10-Q 2011-07-31 Filed 2011-09-02
10-Q 2011-04-30 Filed 2011-06-03
10-Q 2011-01-31 Filed 2011-03-04
10-K 2010-10-31 Filed 2010-12-17
10-Q 2010-07-31 Filed 2010-09-03
10-Q 2010-04-30 Filed 2010-06-04
10-Q 2010-01-31 Filed 2010-03-05
8-K 2020-07-01 Officers, Exhibits
8-K 2020-06-04
8-K 2020-04-01
8-K 2020-03-18
8-K 2020-03-05
8-K 2019-12-10
8-K 2019-12-05
8-K 2019-09-27
8-K 2019-08-29
8-K 2019-05-30
8-K 2019-04-17
8-K 2019-03-18
8-K 2019-03-05
8-K 2018-12-12
8-K 2018-12-06
8-K 2018-11-01
8-K 2018-08-30
8-K 2018-06-07
8-K 2018-05-01
8-K 2018-04-23
8-K 2018-04-10
8-K 2018-03-19
8-K 2018-03-08
8-K 2018-03-08
8-K 2018-01-04

Cooper Companies Financials

COO Metrics, Comps, Filings

Quarterly | Annual

Valuation ($BB)

Market Cap, Enterprise Value

Balance Sheet ($BB)

Assets, Equity

Income Statement ($BB Quarterly)

Revenue, G Profit, Net Income

Cash Flow ($BB Quarterly)

Ops, Inv, Fin

Comps ($MM TTM) Market Cap Gross Margin EV/EBITDA Ret on Assets Assets Liabilities Revenue G Profit Net Income EBITDA EV
AmerisourceBergen (ABC) 18,140 3% 13.0 2% 39,172 36,293 179,589 5,138 856 1,458 18,939
Centene (CNC) 18,130 75% 7.2 4% 34,252 21,816 72,335 53,998 1,354 2,543 18,308
Laboratory of America (LH) 16,500 28% 11.4 4% 17,848 10,597 11,389 3,204 756 1,952 22,240
Teleflex (TFX) 16,169 57% 32.5 7% 6,257 3,404 2,556 1,459 444 551 17,928
Incyte (INCY) 15,860 71% 30.0 13% 3,215 792 2,108 1,497 405 472 14,157
Cooper Companies (COO) 14,712 66% 19.2 7% 6,274 2,646 2,653 1,757 467 826 15,886
Quest Diagnostics (DGX) 14,475 34% 13.0 6% 12,019 6,414 7,639 2,631 780 1,388 18,034
Dexcom (DXCM) 14,282 63% -153.6 -8% 2,186 1,421 1,351 845 -171 -90 13,886
Align Technology (ALGN) 14,137 72% 29.3 14% 2,350 1,045 1,757 1,272 322 465 13,646
Cardinal Health (CAH) 14,081 5% -6.1 -11% 39,179 38,279 147,662 6,847 -4,150 -3,309 20,229
WellCare Health Plans (WCG) 13,524 79% 11.8 5% 13,862 9,005 26,983 21,237 631 1,086 12,860
Hologic (HOLX) 13,366 35% 53.8 -3% 6,442 4,326 3,367 1,171 -204 294 15,819
Universal Health Services (UHS) 13,144 0% 12.2 6% 11,594 6,205 11,237 0 743 1,395 16,959
Biomarin Pharmaceutical (BMRN) 12,700 79% 1,194.1 -1% 4,558 1,484 1,250 986 -39 11 13,147
Seattle Genetics (SGEN) 12,597 0% -42.8 -15% 2,098 318 801 0 -304 -290 12,404
Exact Sciences (EXAS) 11,943 74% -66.8 -12% 1,759 1,011 724 538 -216 -163 10,909
Dentsply Sirona (XRAY) 11,909 52% 27.4 2% 8,367 3,308 3,977 2,079 162 477 13,086
National Vision (EYE) 2,036 56% 33.8 1% 2,078 1,313 1,784 991 10 75 2,525
Staar Surgical (STAA) 1,274 74% 82.8 5% 193 43 142 106 9 14 1,161

Balance Sheet ($MM)2010-07-312010-10-312011-01-312011-04-302011-07-312011-10-312012-01-312012-04-302012-07-312012-10-312013-01-312013-04-302013-07-312013-10-312014-01-312014-04-302014-07-312014-10-312015-01-312015-04-302015-07-312015-10-312016-01-312016-04-302016-07-312016-10-312017-01-312017-04-302017-07-312017-10-312018-01-312018-04-302018-07-312018-10-312019-01-312019-04-302019-07-312019-10-31
Cash3438858813131414257729831742516181716164463101911214689921651568014710511390
Accounts Receivable190197189204218215200203229234241224247230235240262276276267280283279299307291291311336317414433376375390396405435
Inventory234228240249243254273286302320325339340339339346353381390403406420431434430418421438454454506505480469486493502507
PP&E8879199169449549569459791,0181,0601,0761,0921,1281,2411,2951,3711,4211,5261,5221,5891,6431,6511,6481,6961,6611,6031,6361,6751,7181,7581,8471,8871,9021,9302,0092,0382,0872,194
Assets2,5032,5252,5722,6252,6152,6252,5992,6292,8842,9412,9702,9673,0073,1373,1153,2223,3674,4584,3364,3934,4234,4614,4024,6014,5934,4764,6574,7504,7834,8596,2696,4146,2576,1136,2996,2036,1736,274
Accounts Payable425248525962485566856274771087586871168710111411711610688107100100112142108154121146130129142150
Long-Term Debt6245925875244193403842884543483782922153023023023011,2811,3031,1061,0701,1101,3381,4111,4121,3181,4161,3571,1801,1492,3732,4422,2491,9862,0871,8721,4231,263
Liabilities9098588508157286876625917877287206305697146616606911,8701,8191,7771,7291,7871,7951,8561,8551,7761,8371,8101,6901,6833,1123,2263,0302,8052,8732,6612,5572,646
Stockholders' Equity1,5941,6671,7221,8101,8881,9371,9372,0382,0972,1932,2322,3142,4162,4052,4352,5432,6572,5702,5012,6102,6882,6682,6002,7382,7312,7003,1763,3083,628
Income Statement ($MM)2010-07-312010-10-312011-01-312011-04-302011-07-312011-10-312012-01-312012-04-302012-07-312012-10-312013-01-312013-04-302013-07-312013-10-312014-01-312014-04-302014-07-312014-10-312015-01-312015-04-302015-07-312015-10-312016-01-312016-04-302016-07-312016-10-312017-01-312017-04-302017-07-312017-10-312018-01-312018-04-302018-07-312018-10-312019-01-312019-04-302019-07-312019-10-31
Revenue296313293325351361326345378396380386412412405412432468445435462456450484515519499522556562590631660652628654679692
Cost of Revenue120126117124149137116124138144139131144148142144152188169167189202188185198223187178200208219227233221210222229237
Gross Profit176187177202203224210228240253240254268264263268281280276268273253262298317296312344356353371404427430418433451455
R&D910101212121113131414141516161716181617181815171618161718191921222321212223
SG&A111110113129134140132137144152151158152157158156161208174168192180174178182189189193209208226248251249250247250250
Tax4624564841063247136466-1-1-18584548197-7-1012-9678
Net Income40484541385755716772758389577280893162614537527488607610510489-12261101101103122120121
Cash Flow ($MM)2010-07-312010-10-312011-01-312011-04-302011-07-312011-10-312012-01-312012-04-302012-07-312012-10-312013-01-312013-04-302013-07-312013-10-312014-01-312014-04-302014-07-312014-10-312015-01-312015-04-302015-07-312015-10-312016-01-312016-04-302016-07-312016-10-312017-01-312017-04-302017-07-312017-10-312018-01-312018-04-302018-07-312018-10-312019-01-312019-04-302019-07-312019-10-31
Cash Operating6573658711142817811548115103150691261081528011196105909812919310813215419926237102215197200
Cash Investing-33-61-27-24-50-19-20-167-33-32-42-39-76-58-62-56-1,171-65-54-67-102-106-126-137-50-202-29-61-89-1,245-174-52-46-129-54-84-85
Cash Financing-31-12-33-64-64-20-6094-82-14-72-52-23-59-1240872-20-54-30-3185529-10384-74-171-671,21779-189-26393-202-104-139